Skip to main content
Premium Trial:

Request an Annual Quote

Jon Cohen, Geoff Monk

Jon Cohen has been appointed as executive chairman of BioReference Laboratories, a unit of Opko Health.

Most recently, he was senior vice president and group executive for diagnostic solutions at Quest Diagnostics. Prior to that, he was a managing director for health industries services at PricewaterhouseCoopers, and before that, chief medical officer at North Shore-Long Island Jewish Health System. Cohen holds a BS degree from the University of Miami and an MD degree from the University of Miami School of Medicine.

OpkoHealth has also promoted Geoff Monk to president of BioReference Laboratories. He joined the company last year as general manager.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.